This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Petrobras appeals Brazil regulator's approval of Subsea7-Saipem merger

By Flavia Fortes ( July 13, 2026, 21:49 GMT | Insight) -- Brazilian state-controlled oil company Petrobras has appealed the Brazilian competition authority's unconditional approval of the proposed merger between offshore engineering companies Saipem and Subsea7, arguing the agency underestimated the transaction's competitive risks in deepwater subsea installation services. Petrobras is asking CADE's Tribunal to either prohibit the deal or impose structural and behavioral remedies.Brazilian state-controlled oil company Petrobras has appealed the Brazilian competition authority's unconditional approval of the proposed merger between offshore engineering companies Saipem and Subsea7, arguing the agency underestimated the transaction's competitive risks in deepwater subsea installation services. Petrobras is asking CADE's Tribunal to either prohibit the deal or impose structural and behavioral remedies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login